Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets

Abstract : Growth and differentiation factor 15 (GDF15) belongs to the transforming growth factor-β (TGF-β) superfamily proteins. GDF15 acts as an inflammatory marker, and it plays a role in pathogenesis of tumors, ischemic diseases, metabolic disorders, and neurodegenerative processes. GDF15 is not normally expressed in the tissue; it is prominently induced following 'injury'. GDF15 functions are critical for the regulation of endothelial adaptations after vascular damage. Recently, four research groups simultaneously identified glial-derived neurotrophic factor (GDNF)-family receptor α-like (GFRAL) in the brain, an orphan receptor as the receptor for GDF15, signaling through the coreceptor RET. In this article, new aspects of the biology of GDF15 and receptor GFRAL, and their relationship with various pathologies, are commented on.
Liste complète des métadonnées
Contributeur : Catherine Vergely Connectez-vous pour contacter le contributeur
Soumis le : mercredi 3 novembre 2021 - 17:49:43
Dernière modification le : mercredi 3 novembre 2021 - 18:31:07


Publication financée par une institution




Luc Rochette, Marianne Zeller, Yves Cottin, Catherine Vergely. Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets. Trends in Endocrinology and Metabolism = Trends in Endocrinology & Metabolism , Elsevier, 2020, 31 (12), pp.939 - 951. ⟨10.1016/j.tem.2020.10.004⟩. ⟨hal-03413437⟩



Consultations de la notice


Téléchargements de fichiers